David Goldgar, PhD, is a research professor in the Department of Dermatology at the University of Utah and member of the Cancer Control and Population Sciences (CCPS) Program.

Goldgar’s research involves the genetic study of breast cancer and melanoma. He studies methods to clinically classify the BRCA1and BRCA2 genes, the most well-known genes for breast cancer.

Before leaving the University of Utah to assume the position of chief of the Genetic Epidemiology Unit at the International Association of Cancer Research in Lyon, France, Goldgar was a member of the team that led to the localization, cloning, or characterization of the cancer predisposing BRCA1, BRCA2, and CDKN2A (p16) mutations. Goldgar joined the CCPS Program in 2008 upon his return to the University of Utah.

Goldgar earned a bachelor’s degree and PhD from the University of Colorado, Boulder.